Haemophilus b conjugate vaccine contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Haemophilus b conjugate vaccine }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HIBERIX (HAEMOPHILUS B ..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HIBERIX (HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GLAXOSMITHKLINE BIOLOGICALS SA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=745ff8df-1618-4b76-9aa1-6f42752c0dda | publisher = | date = | accessdate = }}</ref> | Severe allergic reaction (e.g., [[anaphylaxis]]) after a previous dose of any H. influenzae type b- or tetanus toxoid-containing vaccine or any component of the vaccine is a contraindication to administration of HIBERIX [see Description].<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HIBERIX (HAEMOPHILUS B CONJUGATE VACCINE (TETANUS TOXOID CONJUGATE)) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GLAXOSMITHKLINE BIOLOGICALS SA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=745ff8df-1618-4b76-9aa1-6f42752c0dda | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 14:44, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Severe allergic reaction (e.g., anaphylaxis) after a previous dose of any H. influenzae type b- or tetanus toxoid-containing vaccine or any component of the vaccine is a contraindication to administration of HIBERIX [see Description].[1]
References
Adapted from the FDA Package Insert.